Natural Killer Cells for Cancer Immunotherapy

  • Author: Angewandte Chemie International Edition
  • Published Date: 01 July 2020
  • Source / Publisher: Angewandte Chemie International Edition/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Natural Killer Cells for Cancer Immunotherapy

Natural killer (NK) cells are a type of immune cell. They can kill cancer and virally infected cells. This is used in NK-based immunotherapy to treat hematological malignancies, i.e., cancers that affect the blood, bone marrow, or lymph nodes. However, targeting specific solid tumors using NK cells is challenging.


Juan Li, Fuzhou University, China, and The Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Huanghao Yang, Fuzhou University, and colleagues have developed a strategy to enhance the efficacy of NK cells. The team prepared specific, universal, and permeable (or "SUPER") NK cells by binding aptamers to NK cell membranes. Aptamers are short DNA or RNA strands or peptides that can selectively bind to a specific target. The team used the aptamers TLS11a and PDL1. TLS11a targets hepatocellular carcinoma (HCC) liver cancer cells. PDL1 blocks the activity of PD1/PDL1 immune checkpoint proteins and, thereby, boosts immune activity against cancer cells. The aptamers were bound to the cell membrane using a click reaction.


The resulting "SUPER" NK cells target liver tumor cells and could be used for enhanced immunotherapy against solid tumors. In addition to the selective targeting and PDL/PDl-1 blocking, the cells secrete interferon-γ (IFNγ), an immunity-related protein that can suppress tumor growth. The used aptamers are low in cost and can be synthesized on a large scale, and the aptamer-equipped NK cells are biocompatible and biodegradable. The cells' target could be changed to other solid tumors of interest by simply changing the aptamers.


 

 

Article Views: 444

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


Magazine of Chemistry Europe (16 European Chemical Societies)published by Wiley-VCH